ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 173 filers reported holding ACCELERON PHARMA INC in Q3 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $36,000 | -18.2% | 924 | -13.2% | 0.00% | 0.0% |
| Q2 2019 | $44,000 | -89.5% | 1,064 | -88.2% | 0.00% | -88.9% |
| Q1 2019 | $419,000 | +6.3% | 8,988 | -0.6% | 0.01% | 0.0% |
| Q4 2018 | $394,000 | -56.3% | 9,044 | -42.5% | 0.01% | -50.0% |
| Q3 2018 | $901,000 | +15.7% | 15,736 | -1.9% | 0.02% | +12.5% |
| Q2 2018 | $779,000 | +39.6% | 16,044 | +12.4% | 0.02% | +166.7% |
| Q1 2018 | $558,000 | – | 14,280 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
| GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
| Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
| GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
| Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
| QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
| Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
| SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
| Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |